Literature DB >> 22477523

Human B cell defects in perspective.

Charlotte Cunningham-Rundles1.   

Abstract

While primary immune defects are generally considered to lead to severe and easily recognized disease in infants and children, a number of genetic defects impairing B cell function may not be clinically apparent or diagnosed until adult life. The commonest of these is common variable immune deficiency, the genetic origins of which are beginning to be at least partially understood. CVID affects ≈ 1/25,000 Caucasians and is characterized by a marked reduction in serum IgG, almost always in serum IgA, and reduced serum IgM in about half of all cases; these defects continue to provide an opportunity to investigate the genes necessary for B cell function in humans. Recently, a small number of genes necessary for normal B cell function have been identified in consanguineous families leading to varying degrees of hypogammaglobulinemia and loss of antibody production. In other studies, whole-exome sequencing and copy number variation, applied to large cohorts, have extended research into understanding both the genetic basis of this syndrome and the clinical phenotypes of CVID.

Entities:  

Mesh:

Year:  2012        PMID: 22477523      PMCID: PMC3474891          DOI: 10.1007/s12026-012-8318-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  61 in total

Review 1.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81.

Authors:  T Miyazaki; U Müller; K S Campbell
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  Role of TNFRSF13B variants in patients with common variable immunodeficiency.

Authors:  Natalia Martínez-Pomar; Drahomíra Detková; Juan I Arostegui; Antonio Alvarez; Pere Soler-Palacín; Antonio Vidaller; Teresa Espanol; Almudena Sampalo; Javier de Gracia; Manuel Hernandez; Jordi Yagüe; Nuria Matamoros
Journal:  Blood       Date:  2009-09-24       Impact factor: 22.113

4.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

6.  Novel mutations in a Japanese patient with CD19 deficiency.

Authors:  H Kanegane; K Agematsu; T Futatani; M M Sira; K Suga; T Sekiguchi; M C van Zelm; T Miyawaki
Journal:  Genes Immun       Date:  2007-09-20       Impact factor: 2.676

Review 7.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

8.  Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.

Authors:  Kohsuke Imai; Geir Slupphaug; Wen-I Lee; Patrick Revy; Shigeaki Nonoyama; Nadia Catalan; Leman Yel; Monique Forveille; Bodil Kavli; Hans E Krokan; Hans D Ochs; Alain Fischer; Anne Durandy
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

9.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  8 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.

Authors:  Falk Nimmerjahn; Anja Lux
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-05       Impact factor: 11.205

Review 3.  Re-thinking the functions of IgA(+) plasma cells.

Authors:  Jennifer L Gommerman; Olga L Rojas; Jörg H Fritz
Journal:  Gut Microbes       Date:  2014

4.  Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells.

Authors:  Janna Schneppenheim; Susann Hüttl; Anne Kruchen; Regina Fluhrer; Ingo Müller; Paul Saftig; Reinhard Schneppenheim; Christa L Martin; Bernd Schröder
Journal:  Biochem Biophys Res Commun       Date:  2014-07-15       Impact factor: 3.575

5.  Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum.

Authors:  Junghee J Shin; Daniel Liauw; Sabrina Siddiqui; Juhyeon Lee; Eun Jae Chung; Ryan Steele; Florence Ida Hsu; Christina Price; Insoo Kang
Journal:  J Clin Immunol       Date:  2020-04-02       Impact factor: 8.317

6.  Hypogammaglobulinemia in BLT humanized mice--an animal model of primary antibody deficiency.

Authors:  Francisco Martinez-Torres; Tomonori Nochi; Angela Wahl; J Victor Garcia; Paul W Denton
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

Review 7.  Genomic modulators of the immune response.

Authors:  Julian C Knight
Journal:  Trends Genet       Date:  2012-11-01       Impact factor: 11.639

8.  Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.

Authors:  Federica Pulvirenti; Ilaria Pentassuglio; Cinzia Milito; Michele Valente; Adriano De Santis; Valentina Conti; Giulia d'Amati; Oliviero Riggio; Isabella Quinti
Journal:  J Immunol Res       Date:  2014-03-31       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.